Xtoro Suspension
Product Images NDC 83709-001
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Xtoro (NDC 83709-001). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Fonseca Biosciences, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Figure1)
Figure 2 (Figure2)
Figure 3 (Figure3)
Figure 4 (Figure4)
Carton (New Carton)
This is a description for XTORO, a finafloxacin otic suspension with a concentration of 0.3%. The product is for topical use in the ear. It should be stored at 2°C-25°C (36°F-77°F) and should not be frozen. Before use, it is recommended to warm the bottle in hands and shake well. The composition of each mL includes 3mg of finafloxacin along with inactive ingredients such as sodium chloride, hydroxyethyl cellulose, magnesium chloride, tyloxapol, benzalkonium chloride (as preservative), and purified water. Adjustments in pH may be made with hydrochloric acid and/or sodium hydroxide.*
Bottle (New Container)
This text provides information about an ear drop medication labeled for topical use in the ear, containing active ingredient finafloxacin 3 mg per mL. It advises to store the product between 2°C - 25°C and not freeze it. The manufacturer is Fonseca Biosciences, LLC, based in Long Beach Twp, NJ, USA. The product is made in Spain and comes in a 5mL container. Please refer to the prescribing information for dosage details.*
Bottle-sample-1-5 (Sample Bottle 1 5)
This text contains information about a sample product not for sale, called XTORO with the active ingredient finafloxacin. Each milliliter of the product contains 3 mg of finafloxacin. It is advised to store the product at a temperature between 2°C - 25°C (36°F - 77°F) and not freeze it. The manufacturer is Fonseca Biosciences based in Long Beach Twp, NJ, USA, with the product being a product of Spain. The NDC number for the product is 83709-001-90, and it seems to be an otic suspension. The product seems to come in a 1.5 mL size.*
Sample-bottle-5 (Sample Bottle 5)
This text provides information about a sample product containing finafloxacin 3 mg per mL solution for otic suspension. It includes storage instructions (2°C - 25°C), a warning not to freeze the product, and advises consulting the prescribing information for dosage details. The manufacturer is Fonseca Biosciences, LLC and the product is a 0.3% suspension. The lot number, NDC code, and location of the manufacturer are also provided.*
Carton-sample-1-5 (Sample Carton 1 5)
This text provides detailed information about XTORO, a finafloxacin otic suspension at 0.3% concentration. It includes the composition of the product, active and inactive ingredients, storage instructions, and manufacturer details. The product is indicated for topical use in the ear and may require adjustment of pH with hydrochloric acid and/or sodium hydroxide. It also mentions the need to warm the bottle in hands and shake well before use.*
Sample-carton-5 (Sample Carton 5)
This is a description of XTORO, a finafloxacin otic suspension used for ear infections. Each mL contains 0.3% finafloxacin, totaling 3mg of the active ingredient. The dosage information is available in the prescribing information. The bottle should be warmed and shaken well before use. The storage requirements state it should be stored at 2°C-25°C (36°F-77°F) and should not be frozen. Produced by Fonseca Biosciences, a product of Spain.*
Pouch-sample-1-5 (Sample Pouch 1 5)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.